I am betting this team is putting together the "Shock and Awe" plans for uplist. Be it now or 2017. GC himself said market conditions could and would dictate that plan. The capital markets crash of 2008 forced AMBS to delay going to the OTC. I am glad it came to market when it did. I believe we all will be. The longer your timeline the better. Dividend reinvestment with compound growth. If the science proves itself, I could see an uplist with a spinoff before the uplist. That would neutralize the negative effect of sellers. People will buy for the two company's and hold. If you sell you get your gain but lose ownership in each company.
The list that JP started Saturday, was put together in good faith as a tool for those that are new to AMBS. Also for those that wanted to be in awe of the catalysts we are actually facing after being invested for almost 2 years as myself and others have. I'm saying if you get your hope's up you should. This is a solid calculated risk at this point. The risks are much less than they were at .0051 PPS two years ago.
Please Don't insult the efforts of others. This is not IFlop and in spite of today it will not become the YMB.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links